142 related articles for article (PubMed ID: 3012375)
41. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
Fouque F; Vargaftig BB
Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
[TBL] [Abstract][Full Text] [Related]
42. Plasma concentrations of platelet-specific proteins and serum thromboxane B2 production in response to treatment with dipyridamole. A pilot study of 27 post-myocardial infarction patients.
Safai-Kutti S; Kutti J; Vedin A; Wilhelmsson C
Eur Heart J; 1985 Jun; 6(6):468-72. PubMed ID: 2412820
[TBL] [Abstract][Full Text] [Related]
43. Insulin directly reduces platelet sensitivity to aggregating agents. Studies in vitro and in vivo.
Trovati M; Anfossi G; Cavalot F; Massucco P; Mularoni E; Emanuelli G
Diabetes; 1988 Jun; 37(6):780-6. PubMed ID: 2838353
[TBL] [Abstract][Full Text] [Related]
44. Antiplatelet effect of demethyldiisoeugenol.
Liao CH; Ko FN; Kuo YH; Teng CM
Can J Physiol Pharmacol; 1996 Oct; 74(10):1111-6. PubMed ID: 9022830
[TBL] [Abstract][Full Text] [Related]
45. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
Yu SM; Wu TS; Teng CM
Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
[TBL] [Abstract][Full Text] [Related]
46. Plasmin inhibition of platelet function and of arachidonic acid metabolism.
Schafer AI; Adelman B
J Clin Invest; 1985 Feb; 75(2):456-61. PubMed ID: 3156149
[TBL] [Abstract][Full Text] [Related]
47. Human platelet aggregation and release reaction induced by platelet activating factor (PAF-acether)--effects of acetylsalicylic acid and external ionized calcium.
Cattaneo M; Canciani MT; Mannucci PM
Thromb Haemost; 1985 Apr; 53(2):221-4. PubMed ID: 3927505
[TBL] [Abstract][Full Text] [Related]
48. Influence of phentolamine on platelet aggregation, thromboxane B2 production and release reaction.
Anfossi G; Trovati M; Mularoni E; Lanzio M; Massucco P; Emanuelli G
Arch Int Pharmacodyn Ther; 1988; 296():144-54. PubMed ID: 2853612
[TBL] [Abstract][Full Text] [Related]
49. Prostacyclin prolongs viability of washed human platelets.
Blackwell GJ; Radomski M; Vargas JR; Moncada S
Biochim Biophys Acta; 1982 Sep; 718(1):60-5. PubMed ID: 6291622
[TBL] [Abstract][Full Text] [Related]
50. Immediate effects of heparin and LMW heparin on some platelet and endothelial derived factors.
Ljungberg B; Beving H; Egberg N; Johnsson H; Vesterqvist O
Thromb Res; 1988 Jul; 51(2):209-17. PubMed ID: 2847353
[TBL] [Abstract][Full Text] [Related]
51. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
Siess W; Roth P; Weber PC
Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
[TBL] [Abstract][Full Text] [Related]
52. Kinetics of the beta-thromboglobulin release from alpha-granules of blood platelets activated by ADP.
Walkowiak B; Cierniewski CS
Thromb Res; 1987 Jun; 46(5):727-36. PubMed ID: 2957817
[TBL] [Abstract][Full Text] [Related]
53. Antiplatelet effect of marchantinquinone, isolated from Reboulia hemisphaerica, in rabbit washed platelets.
Liao CH; Ko FN; Wu CL; Teng CM
J Pharm Pharmacol; 2000 Mar; 52(3):353-9. PubMed ID: 10757426
[TBL] [Abstract][Full Text] [Related]
54. The effect of pyridoxal-5-phosphate on the inhibition of platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation in human platelets.
Zahavi M; Zahavi J; Kakkar VV
Life Sci; 1984 Oct; 35(14):1497-503. PubMed ID: 6090838
[TBL] [Abstract][Full Text] [Related]
55. Antiplatelet effects of chelerythrine chloride isolated from Zanthoxylum simulans.
Ko FN; Chen IS; Wu SJ; Lee LG; Haung TF; Teng CM
Biochim Biophys Acta; 1990 May; 1052(3):360-5. PubMed ID: 2162213
[TBL] [Abstract][Full Text] [Related]
56. Patients with paroxysmal atrial fibrillation but not paroxysmal supraventricular tachycardia display evidence of platelet activation during arrhythmia.
Atalar E; Haznedaroglu IC; Acil T; Ozer N; Kilic H; Ovunc K; Aksoyek S; Nazli N; Kes S; Kabakçi G; Kirazli S; Ozmen F
Platelets; 2003; 14(7-8):407-11. PubMed ID: 14713509
[TBL] [Abstract][Full Text] [Related]
57. Systemic and transcardiac platelet activity in acute myocardial infarction in man: resistance to prostacyclin.
Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
Circulation; 1985 Dec; 72(6):1336-45. PubMed ID: 2933181
[TBL] [Abstract][Full Text] [Related]
58. Wines and grape juices as modulators of platelet aggregation in healthy human subjects.
Pace-Asciak CR; Rounova O; Hahn SE; Diamandis EP; Goldberg DM
Clin Chim Acta; 1996 Mar; 246(1-2):163-82. PubMed ID: 8814965
[TBL] [Abstract][Full Text] [Related]
59. Antiplatelet effect of a new inhibitor of thromboxane synthase and thromboxane A2 receptors.
Tubaro E; Belogi L; Mezzadri CM
Arzneimittelforschung; 1996 Jan; 46(1):35-41. PubMed ID: 8821515
[TBL] [Abstract][Full Text] [Related]
60. Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil.
Han P; Boatwright C; Ardlie NG
Thromb Haemost; 1983 Aug; 50(2):513-7. PubMed ID: 6314581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]